Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0032991 | protein-containing complex | 1 | 7 |
GO:1990904 | ribonucleoprotein complex | 2 | 7 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005685 | U1 snRNP | 5 | 1 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097525 | spliceosomal snRNP complex | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120114 | Sm-like protein family complex | 2 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4HQM1
Term | Name | Level | Count |
---|---|---|---|
GO:0000365 | mRNA trans splicing, via spliceosome | 9 | 1 |
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 1 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 1 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008380 | RNA splicing | 7 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
GO:0017069 | snRNA binding | 5 | 1 |
GO:0030619 | U1 snRNA binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.448 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.425 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.432 |
DEG_APCC_DBOX_1 | 18 | 26 | PF00400 | 0.410 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.362 |
DEG_SCF_FBW7_1 | 98 | 105 | PF00400 | 0.273 |
DOC_CYCLIN_RxL_1 | 17 | 27 | PF00134 | 0.416 |
DOC_CYCLIN_RxL_1 | 66 | 76 | PF00134 | 0.420 |
DOC_CYCLIN_RxL_1 | 91 | 101 | PF00134 | 0.389 |
DOC_MAPK_gen_1 | 19 | 25 | PF00069 | 0.508 |
DOC_MAPK_gen_1 | 40 | 48 | PF00069 | 0.421 |
DOC_MAPK_HePTP_8 | 96 | 108 | PF00069 | 0.378 |
DOC_MAPK_MEF2A_6 | 99 | 108 | PF00069 | 0.389 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.414 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.571 |
DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.391 |
LIG_14-3-3_CanoR_1 | 19 | 23 | PF00244 | 0.440 |
LIG_14-3-3_CanoR_1 | 28 | 33 | PF00244 | 0.422 |
LIG_14-3-3_CanoR_1 | 43 | 49 | PF00244 | 0.284 |
LIG_Actin_WH2_2 | 127 | 143 | PF00022 | 0.264 |
LIG_Clathr_ClatBox_1 | 58 | 62 | PF01394 | 0.426 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.526 |
LIG_FHA_1 | 99 | 105 | PF00498 | 0.403 |
LIG_LIR_Gen_1 | 2 | 11 | PF02991 | 0.399 |
LIG_LIR_Gen_1 | 93 | 103 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 101 | 106 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 153 | 159 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 2 | 6 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 93 | 98 | PF02991 | 0.378 |
LIG_LYPXL_SIV_4 | 102 | 110 | PF13949 | 0.419 |
LIG_PTB_Apo_2 | 5 | 12 | PF02174 | 0.433 |
LIG_PTB_Apo_2 | 97 | 104 | PF02174 | 0.415 |
LIG_PTB_Phospho_1 | 97 | 103 | PF10480 | 0.408 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.481 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.359 |
LIG_SH3_2 | 79 | 84 | PF14604 | 0.461 |
LIG_SH3_3 | 6 | 12 | PF00018 | 0.408 |
LIG_SH3_3 | 72 | 78 | PF00018 | 0.433 |
LIG_SUMO_SIM_anti_2 | 56 | 62 | PF11976 | 0.379 |
LIG_SUMO_SIM_par_1 | 115 | 121 | PF11976 | 0.461 |
LIG_SUMO_SIM_par_1 | 135 | 142 | PF11976 | 0.507 |
LIG_SUMO_SIM_par_1 | 56 | 62 | PF11976 | 0.440 |
LIG_TRAF2_1 | 53 | 56 | PF00917 | 0.441 |
LIG_TYR_ITSM | 99 | 106 | PF00017 | 0.397 |
LIG_WRC_WIRS_1 | 45 | 50 | PF05994 | 0.419 |
MOD_CDC14_SPxK_1 | 81 | 84 | PF00782 | 0.465 |
MOD_CDK_SPxK_1 | 78 | 84 | PF00069 | 0.459 |
MOD_CK1_1 | 146 | 152 | PF00069 | 0.618 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.357 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.552 |
MOD_GlcNHglycan | 50 | 54 | PF01048 | 0.361 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.462 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.600 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.400 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.347 |
MOD_N-GLC_2 | 125 | 127 | PF02516 | 0.407 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.362 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.570 |
MOD_NEK2_2 | 123 | 128 | PF00069 | 0.424 |
MOD_PK_1 | 28 | 34 | PF00069 | 0.423 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.382 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.292 |
MOD_Plk_1 | 134 | 140 | PF00069 | 0.470 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.337 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.469 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.385 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.567 |
MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.398 |
TRG_DiLeu_BaEn_1 | 135 | 140 | PF01217 | 0.415 |
TRG_DiLeu_BaEn_1 | 56 | 61 | PF01217 | 0.271 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.446 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NL51 | Trypanosomatidae | 34% | 100% |
A0A3R7MQF7 | Trypanosoma rangeli | 35% | 100% |
A0A3S7XCG8 | Leishmania donovani | 90% | 100% |
A4ICD9 | Leishmania infantum | 90% | 100% |
D0A3S5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9AUD6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q054 | Leishmania major | 90% | 100% |